Literature DB >> 2666213

The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.

A Signore1, P Pozzilli, E A Gale, D Andreani, P C Beverley.   

Abstract

A longitudinal study of lymphocytic infiltration in the endocrine pancreas of non-obese diabetic mice was performed to investigate the role of different lymphocyte subsets in the pathogenesis of diabetes. The incidence of insulitis and the percentage of mononuclear cell subsets in the pancreas were evaluated in non-obese diabetic mice of various ages (5, 9, 13, 17, 22, 29 and 36 weeks). Cryostat sections of pancreas were stained with heamatoxilin-eosin or with different monoclonal antibodies against total T lymphocytes, helper T lymphocytes, cytotoxic/suppressor T lymphocytes, activated interleukin 2 receptor positive lymphocytes and B lymphocytes. A monoclonal antibody against Class-II antigens was also used. Positive cells were revealed by the immunoperoxidase technique. Insulitis was found in 5 weeks old mice but to a lesser extent than in adult animals. No significant variation between infiltrating cell subsets was found in different age groups. T lymphocytes ranged between 20.4% and 28.1%, B lymphocytes between 28.8% and 30.8% and Class-II positive cells between 22.8% and 32.2%. Interleukin 2 receptor positive cells ranged between 5.5% and 8.5% as detected with AMT-13 monoclonal antibody which recognise the interleukin 2 binding site. A higher percentage of activated cells was observed using another monoclonal antibody (7D4) directed against a different epitope of the interleukin 2 receptor, suggesting the presence of activated lymphocytes with interleukin 2 receptors saturated by interleukin 2. No insulin-containing cells were found to express Class-II molecules as demonstrated by a double immunofluorescence technique. Most infiltrating mononuclear cells were found to be positive for Class-II and L3T4 antigens or to be Class-II positive and express surface immunoglobulins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666213     DOI: 10.1007/bf00265543

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes.

Authors:  J A Shizuru; C Taylor-Edwards; B A Banks; A K Gregory; C G Fathman
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

2.  Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies.

Authors:  M A Talle; P E Rao; E Westberg; N Allegar; M Makowski; R S Mittler; G Goldstein
Journal:  Cell Immunol       Date:  1983-05       Impact factor: 4.868

3.  Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study.

Authors:  O Pontesilli; P Carotenuto; L S Gazda; P F Pratt; S J Prowse
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

4.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

5.  Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity.

Authors:  S Kataoka; J Satoh; H Fujiya; T Toyota; R Suzuki; K Itoh; K Kumagai
Journal:  Diabetes       Date:  1983-03       Impact factor: 9.461

6.  Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice.

Authors:  M Prochazka; E H Leiter; D V Serreze; D L Coleman
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

7.  Recombinant interleukin 2 enhances spontaneous insulin-dependent diabetes in BB rats.

Authors:  H Kolb; J Zielasek; U Treichel; G Freytag; M Wrann; U Kiesel
Journal:  Eur J Immunol       Date:  1986-02       Impact factor: 5.532

8.  Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody.

Authors:  M Harada; S Makino
Journal:  Jikken Dobutsu       Date:  1986-10

9.  Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis.

Authors:  V E Kelley; G N Gaulton; M Hattori; H Ikegami; G Eisenbarth; T B Strom
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

10.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.

Authors:  A Bendelac; C Carnaud; C Boitard; J F Bach
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  40 in total

Review 1.  Etiology of autoimmunity.

Authors:  N Sarvetnick
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

3.  Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice.

Authors:  John A Gebe; Kellee A Unrath; Ben A Falk; Kouichi Ito; Li Wen; Terri L Daniels; Ake Lernmark; Gerald T Nepom
Journal:  Clin Immunol       Date:  2006-09-18       Impact factor: 3.969

4.  Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products.

Authors:  C Boitard; M C Villa; C Becourt; H P Gia; C Huc; P Sempe; M M Portier; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

5.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.

Authors:  L Wen; F S Wong; L Burkly; M Altieri; C Mamalaki; D Kioussis; R A Flavell; R S Sherwin
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

6.  Antibody Binding to CD4 Induces Rac GTPase Activation and Alters T Cell Migration.

Authors:  Y Maurice Morillon; Elizabeth Chase Lessey-Morillon; Matthew Clark; Rui Zhang; Bo Wang; Keith Burridge; Roland Tisch
Journal:  J Immunol       Date:  2016-09-30       Impact factor: 5.422

7.  Baclofen, a gamma-aminobutyric acid-b receptor agonist, delays diabetes onset in the non-obese diabetic mouse.

Authors:  P E Beales; M Hawa; A J Williams; M C Albertini; A Giorgini; P Pozzilli
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

8.  The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines.

Authors:  A Kasuga; T Maruyama; I Takei; A Shimada; T Kasatani; K Watanabe; T Saruta; T Nakaki; S Habu; J Miyazaki
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

9.  Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.

Authors:  N Chosich; L C Harrison
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

10.  Efficient culture of CD8(+) T cells from the islets of NOD mice and their use for the study of autoreactive specificities.

Authors:  Irene Jarchum; Toshiyuki Takaki; Teresa P DiLorenzo
Journal:  J Immunol Methods       Date:  2008-09-07       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.